- Report
- July 2021
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- June 2021
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- March 2021
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2019
- 159 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2025
- 250 Pages
Global
From €4452EUR$4,999USD£3,863GBP
- Report
- January 2025
- 250 Pages
Global
From €4452EUR$4,999USD£3,863GBP
- Report
- October 2024
- 250 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- September 2024
- 250 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- August 2024
- 240 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- August 2024
- 200 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- July 2024
- 200 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- July 2024
- 200 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- May 2024
- 160 Pages
Global
From €4426EUR$4,969USD£3,840GBP
- Report
- May 2024
- 160 Pages
Global
From €4426EUR$4,969USD£3,840GBP
- Report
- December 2023
- 221 Pages
Global
From €3206EUR$3,599USD£2,781GBP
- Report
- September 2023
- 200 Pages
Global
From €3206EUR$3,599USD£2,781GBP
- Report
- July 2023
- 160 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- May 2023
- 140 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- May 2023
- 147 Pages
Global
From €4408EUR$4,949USD£3,824GBP
- Report
- May 2023
- 160 Pages
Global
From €4408EUR$4,949USD£3,824GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more